Table 2.
Characteristics of the text-based symptom-monitoring program by cancer type
| Ovarian cancer (N = 70) [n (%)] |
Endometrial cancer (N = 50) [n (%)] |
Breast cancer (N = 193) [n (%)] |
|
|---|---|---|---|
| Already enrolled in MyChart | 50 (71.4%) | 27 (54.0%) | 155 (78.8%) |
| MyChart enrollment refusals among those not already enrolled* | 10/20 (50.0%) | 11/23 (47.8%) | 10/28 (35.7%) |
| Provided with an iPhone | 10 (14.3%) | 4 (8.0%) | 28 (14.2%) |
|
Adherence to monthly surveys [% (range)] |
77.5% (67%-88%) |
75.5% (71–86%) |
73.5% (64–83%) |
| Staff administered monthly surveys | 7 (10.0%) | 4 (8.0%) | 10 (5.1%) |
| Patient withdraws | 5 (7.1%) | 9 (18.0%) | 13 (6.7%) |
| Patient deaths | 17 (24.2%) | 2 (4.0%) | 11 (5.7%) |
| PHQ-9 scores ≥ 10 and/or with suicidal ideation | 24 (34.3%) | 15 (30.0%) | 0 (0.0%)** |
| Received navigation services | 9 (12.9%) | 7 (14.0%) | 53 (27.4%) |
*This is presented as the number of patients refusing to enroll divided by the number of patients not enrolled in MyChart at the start of the symptom-monitoring program
**The PHQ-9 was not administered in the breast clinic as part of this program